| R&D Center |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Medicine project |
Now Position:Home > R&D Center > Medicine project |
|
| Item Number |
Product Name |
Registry Classification |
Indication |
Progress |
| 001 |
Apremilast (CC-10004) |
H 3+3 |
N.A |
N.A |
| 002 |
eliglustat |
H 3+3 |
N.A |
N.A |
| 003 |
LCZ-696 |
H 3+3 |
N.A |
N.A |
| 004 |
palbociclib |
H 3+3 |
N.A |
N.A |
| 005 |
Trelagliptin (succinate) |
H 3+3 |
N.A |
N.A |
| 006 |
Obeticholic Acid |
H 3+3 |
N.A |
N.A |
| 007 |
Clemastine fumarate |
H 6+6 |
N.A |
N.A |
| 008 |
Bortezomib |
H 3+6 |
N.A |
N.A |
| 009 |
Etoricoxib |
H 3+6 |
N.A |
N.A |
| 010 |
Ezetimibe |
H 3+6 |
N.A |
N.A |
| 011 |
To be Named |
H 1+1 |
N.A |
Molecular structure determined, in pharmaceutical research |
| 012 |
HAP-SN-38 |
H 1+1 |
N.A |
Synthesis process finished, in pharmaceutical research |
| 013 |
To be Named |
H 1+1 |
N.A |
Molecular structure determined, in pharmaceutical research |
| 014 |
Valsartan |
H 6+6 |
Primary hypertension. |
completed |
| 015 |
Co-Diovan |
H 6+6 |
N.A |
N.A |
| 016 |
Alprazolam Tablets |
conformance assessment |
It is mainly used for anxiety, nervousness, and agitation. It can also be used as an adjuvant for hypnosis or anxiety. It can also be used as an anti-panic drug and can alleviate acute alcohol withdrawal symptoms. Patients with depression should be used with caution. |
|
| 017 |
Lithium Carbonate Tablets |
conformance assessment |
It mainly treats mania, has a good treatment and prevention of recurrence for bipolar affective disorder with alternating episodes of mania and depression, and also has a preventive effect on recurrent depression. Also used to treat split-emotional psychosis. |
|
| 018 |
Zopiclone Tablets |
conformance assessment |
For all kinds of insomnia. |
|
| 019 |
Hydrochlorothiazide Tablets |
conformance assessment |
1. Edema disease excretes excess sodium and water in the body, reduces extracellular fluid volume, and eliminates edema. Common include congestive heart failure, cirrhosis ascites, nephrotic syndrome, acute and chronic nephritis edema, early chronic renal failure, adrenocortical hormone and estrogen treatment caused by sodium, water retention.
2. Hypertension can be used alone or in combination with other antihypertensive drugs, mainly for the treatment of essential hypertension.
3. Central or renal diabetes insipidus.
4. Kidney stone disease is mainly used to prevent stones formed by calcium salt components. |
|
| 020 |
spironolactone tablets |
conformance assessment |
1, edema disease combined with other diuretics, treatment of congestive edema, cirrhosis ascites, renal edema and other edematous diseases, the purpose is to correct the above-mentioned diseases associated with increased secondary aldosterone secretion, and against other diuretics The role of potassium. Also used for the treatment of idiopathic edema.
2, high blood pressure as an auxiliary drug for the treatment of hypertension.
3, primary aldosteronism spironolactone can be used for the diagnosis and treatment of this disease.
4. Prevention of hypokalemia Combined with thiazide diuretics, it enhances diuretic effect and prevents hypokalemia. |
|
|
|
|
